Report Detail
Global Tumor Blood Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4511507 |
- 16 February, 2023 |
- Global |
- 88 Pages |
- GIR (Global Info Research) |
- Other
According to our (Global Info Research) latest study, the global Tumor Blood Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Tumor Blood Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Tumor Blood Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Tumor Blood Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Tumor Blood Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Tumor Blood Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tumor Blood Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tumor Blood Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Guardant Health, Trovagene, Genomic Health, Roche and Bio-Techne and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Tumor Blood Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Blood Protein Testing
Tumor Marker Testing
Others
Market segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Market segment by players, this report covers
Guardant Health
Trovagene
Genomic Health
Roche
Bio-Techne
Pathway Genomics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Tumor Blood Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Tumor Blood Testing, with revenue, gross margin and global market share of Tumor Blood Testing from 2018 to 2023.
Chapter 3, the Tumor Blood Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Tumor Blood Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Tumor Blood Testing.
Chapter 13, to describe Tumor Blood Testing research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Tumor Blood Testing
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Tumor Blood Testing by Type
- 1.3.1 Overview: Global Tumor Blood Testing Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Tumor Blood Testing Consumption Value Market Share by Type in 2022
- 1.3.3 Blood Protein Testing
- 1.3.4 Tumor Marker Testing
- 1.3.5 Others
- 1.4 Global Tumor Blood Testing Market by Application
- 1.4.1 Overview: Global Tumor Blood Testing Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.4.4 Ambulatory Surgical Centers
- 1.5 Global Tumor Blood Testing Market Size & Forecast
- 1.6 Global Tumor Blood Testing Market Size and Forecast by Region
- 1.6.1 Global Tumor Blood Testing Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Tumor Blood Testing Market Size by Region, (2018-2029)
- 1.6.3 North America Tumor Blood Testing Market Size and Prospect (2018-2029)
- 1.6.4 Europe Tumor Blood Testing Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Tumor Blood Testing Market Size and Prospect (2018-2029)
- 1.6.6 South America Tumor Blood Testing Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Tumor Blood Testing Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Guardant Health
- 2.1.1 Guardant Health Details
- 2.1.2 Guardant Health Major Business
- 2.1.3 Guardant Health Tumor Blood Testing Product and Solutions
- 2.1.4 Guardant Health Tumor Blood Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Guardant Health Recent Developments and Future Plans
- 2.2 Trovagene
- 2.2.1 Trovagene Details
- 2.2.2 Trovagene Major Business
- 2.2.3 Trovagene Tumor Blood Testing Product and Solutions
- 2.2.4 Trovagene Tumor Blood Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Trovagene Recent Developments and Future Plans
- 2.3 Genomic Health
- 2.3.1 Genomic Health Details
- 2.3.2 Genomic Health Major Business
- 2.3.3 Genomic Health Tumor Blood Testing Product and Solutions
- 2.3.4 Genomic Health Tumor Blood Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Genomic Health Recent Developments and Future Plans
- 2.4 Roche
- 2.4.1 Roche Details
- 2.4.2 Roche Major Business
- 2.4.3 Roche Tumor Blood Testing Product and Solutions
- 2.4.4 Roche Tumor Blood Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Roche Recent Developments and Future Plans
- 2.5 Bio-Techne
- 2.5.1 Bio-Techne Details
- 2.5.2 Bio-Techne Major Business
- 2.5.3 Bio-Techne Tumor Blood Testing Product and Solutions
- 2.5.4 Bio-Techne Tumor Blood Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Bio-Techne Recent Developments and Future Plans
- 2.6 Pathway Genomics
- 2.6.1 Pathway Genomics Details
- 2.6.2 Pathway Genomics Major Business
- 2.6.3 Pathway Genomics Tumor Blood Testing Product and Solutions
- 2.6.4 Pathway Genomics Tumor Blood Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Pathway Genomics Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Tumor Blood Testing Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Tumor Blood Testing by Company Revenue
- 3.2.2 Top 3 Tumor Blood Testing Players Market Share in 2022
- 3.2.3 Top 6 Tumor Blood Testing Players Market Share in 2022
- 3.3 Tumor Blood Testing Market: Overall Company Footprint Analysis
- 3.3.1 Tumor Blood Testing Market: Region Footprint
- 3.3.2 Tumor Blood Testing Market: Company Product Type Footprint
- 3.3.3 Tumor Blood Testing Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Tumor Blood Testing Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Tumor Blood Testing Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Tumor Blood Testing Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Tumor Blood Testing Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Tumor Blood Testing Consumption Value by Type (2018-2029)
- 6.2 North America Tumor Blood Testing Consumption Value by Application (2018-2029)
- 6.3 North America Tumor Blood Testing Market Size by Country
- 6.3.1 North America Tumor Blood Testing Consumption Value by Country (2018-2029)
- 6.3.2 United States Tumor Blood Testing Market Size and Forecast (2018-2029)
- 6.3.3 Canada Tumor Blood Testing Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Tumor Blood Testing Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Tumor Blood Testing Consumption Value by Type (2018-2029)
- 7.2 Europe Tumor Blood Testing Consumption Value by Application (2018-2029)
- 7.3 Europe Tumor Blood Testing Market Size by Country
- 7.3.1 Europe Tumor Blood Testing Consumption Value by Country (2018-2029)
- 7.3.2 Germany Tumor Blood Testing Market Size and Forecast (2018-2029)
- 7.3.3 France Tumor Blood Testing Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Tumor Blood Testing Market Size and Forecast (2018-2029)
- 7.3.5 Russia Tumor Blood Testing Market Size and Forecast (2018-2029)
- 7.3.6 Italy Tumor Blood Testing Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Tumor Blood Testing Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Tumor Blood Testing Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Tumor Blood Testing Market Size by Region
- 8.3.1 Asia-Pacific Tumor Blood Testing Consumption Value by Region (2018-2029)
- 8.3.2 China Tumor Blood Testing Market Size and Forecast (2018-2029)
- 8.3.3 Japan Tumor Blood Testing Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Tumor Blood Testing Market Size and Forecast (2018-2029)
- 8.3.5 India Tumor Blood Testing Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Tumor Blood Testing Market Size and Forecast (2018-2029)
- 8.3.7 Australia Tumor Blood Testing Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Tumor Blood Testing Consumption Value by Type (2018-2029)
- 9.2 South America Tumor Blood Testing Consumption Value by Application (2018-2029)
- 9.3 South America Tumor Blood Testing Market Size by Country
- 9.3.1 South America Tumor Blood Testing Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Tumor Blood Testing Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Tumor Blood Testing Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Tumor Blood Testing Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Tumor Blood Testing Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Tumor Blood Testing Market Size by Country
- 10.3.1 Middle East & Africa Tumor Blood Testing Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Tumor Blood Testing Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Tumor Blood Testing Market Size and Forecast (2018-2029)
- 10.3.4 UAE Tumor Blood Testing Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Tumor Blood Testing Market Drivers
- 11.2 Tumor Blood Testing Market Restraints
- 11.3 Tumor Blood Testing Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Tumor Blood Testing Industry Chain
- 12.2 Tumor Blood Testing Upstream Analysis
- 12.3 Tumor Blood Testing Midstream Analysis
- 12.4 Tumor Blood Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Tumor Blood Testing. Industry analysis & Market Report on Tumor Blood Testing is a syndicated market report, published as Global Tumor Blood Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Tumor Blood Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
